SCHEMBL18178300

SCHEMBL18178300

COC(=O)Oc1ccccc1COc1cc(Cl)c(C)cc1C(F)F

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 2/20 0.43
FABP5 Q01469 2/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.42
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 1/20 0.41
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HDAC8 Q9BY41 3/20 0.39
FFAR4 Q5NUL3 2/20 0.39
FFAR1 O14842 1/20 0.39
NPC1 O15118 2/20 0.38
MRGPRX4 Q96LA9 4/20 0.38
ANO1 Q5XXA6 1/20 0.37
MEN1 O00255 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178398 0.91 PTGDR2 (0.40) FABP4FABP5PTGDR2KDM4EHPGD
SCHEMBL18156416 0.89 FABP4 (0.43) FABP4FABP5PTGDR2TP53HTT
SCHEMBL18178700 0.89 PTGDR2 (0.42) FABP4FABP5PTGDR2TP53HTT
SCHEMBL18178198 0.88 PARP10 (0.40) FABP4FABP5PTGDR2HTTLMNA
SCHEMBL18178302 0.87 MRGPRX4 (0.38) FABP4FABP5PTGDR2HTTLMNA
SCHEMBL18178279 0.87 PTGDR2 (0.49) FABP4FABP5PTGDR2TP53HTT
SCHEMBL18178263 0.87 PTGDR2 (0.46) FABP4FABP5PTGDR2TP53HTT
SCHEMBL18178307 0.86 FABP4 (0.37) FABP4FABP5PTGDR2TP53HTT
SCHEMBL18178244 0.86 PTGDR2 (0.44) FABP4FABP5PTGDR2TP53HTT
SCHEMBL18178304 0.86 LMNA (0.39) FABP4FABP5HTTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 FABP4 4134/4885FABP5 3786/4885PTGDR2 4455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.